Skip to main navigation
Skip to search
Skip to main content
MD Anderson Cancer Center Home
Help & FAQ
Home
Profiles
Research units
Equipment
Research output
Activities
Prizes
Search by expertise, name or affiliation
View Scopus Profile
Yao Yu
Assistant Professor
Epidemiology
h-index
1425
Citations
19
h-index
Calculated based on number of publications stored in Pure and citations from Scopus
2008
2025
Research activity per year
Overview
Fingerprint
Network
Research output
(50)
Similar Profiles
(6)
Fingerprint
Dive into the research topics where Yao Yu is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Biochemistry, Genetics and Molecular Biology
Germ Cell
68%
Germline
68%
Haplotype
54%
Exome Sequencing
49%
Gene Expression
45%
Genetics
38%
Evolution
36%
Rare Variant
36%
Lymphocyte
36%
Body Composition
36%
Genetic Risk
33%
Single-Nucleotide Polymorphism
30%
PALB2
27%
Cancer Cell
27%
Genomics
24%
Candidate Gene
22%
Phosphotransferase
22%
Kinase
22%
Exome
22%
Transcription
22%
Genetic Divergence
21%
Induced Pluripotent Stem Cell
20%
Whole Genome Sequencing
20%
Somatic Mutation
19%
Camellia Sinensis
18%
Quality Control
18%
Massively Parallel Signature Sequencing
18%
EPAS1
18%
DNA Sequence
18%
BAG1
18%
S Phase
18%
BRCA2
18%
Trans Splicing
18%
B Cell
18%
Membrane Protein
18%
Transmembrane Protein
18%
Retinoblastoma
18%
Substrate Interaction
18%
Epitranscriptomics
18%
Polymerase
18%
Pedigree
18%
DNA Polymerase Epsilon
18%
Hematopoiesis
18%
RNA
18%
Transcription Regulation
18%
ERBB3
18%
Influenza Virus
18%
Heart Conduction
18%
Filtration
18%
Gene Expression Data
18%
Keyphrases
Prostate Cancer
55%
Apalutamide
47%
Prostate Cancer Risk
43%
Germ Cells
38%
Phase II Trial
36%
ErbB2
36%
Molecular Predictors
36%
Intermediate-risk Prostate Cancer
36%
Body Composition
36%
Confidence Interval
35%
European Ancestry
33%
Odds Ratio
29%
Susceptibility Genes
27%
Radical Prostatectomy
24%
Targeted Sequencing
22%
Cancer Cases
22%
PALB2
21%
Whole Exome
20%
Liver Transcriptome
18%
Secondary Metabolic Pathway
18%
Tea Plant
18%
IMAGe Syndrome
18%
Chimeric Antigen Receptor T-cell Therapy
18%
Apicomplexa
18%
PB2 Subunit
18%
Biochemical Recurrence
18%
Small Bowel Adenocarcinoma
18%
Genetic Variant Interpretation
18%
Nicotine Consumption
18%
Subpath
18%
Golgi Membrane Protein 1
18%
KORA Study
18%
Pancreatic Cancer
18%
Rare Germline Variants
18%
Melanoma
18%
RNA Editome
18%
Cardiac Conduction System
18%
Multi-protein
18%
ErbB3
18%
Large B-cell Lymphoma
18%
Tissue Gene Expression
18%
Population-based
18%
RBM39
18%
Hybrid Assembly
18%
Context Mining
18%
Lactobacillus Bulgaricus
18%
Whey
18%
DNA Sequencing
18%
Network Map
18%
Hereditary Retinoblastoma
18%
Medicine and Dentistry
Prostate Cancer
100%
Apalutamide
54%
Phase II Trials
40%
Diseases
32%
Cancer Risk
28%
Breast Cancer
24%
Prostatectomy
24%
Germ Cell
23%
Abiraterone Acetate
21%
Chimeric Antigen Receptor T-Cell Immunotherapy
18%
Influenza A Virus
18%
Adenocarcinoma
18%
Melanoma
18%
DNA Sequence
18%
Androgen
18%
In Silico
18%
Pathogenicity
18%
Prednisone
18%
Biochemical Recurrence
18%
Conditioning
18%
Checkpoint Kinase 2
18%
Hematopoiesis
18%
Lymphocyte
18%
Castration Resistant Prostate Cancer
18%
Large-Cell Lymphoma
18%
Cell Signaling Pathway
18%
Membrane Protein
18%
Ovarian Cancer
18%
Hormone Therapy
18%
Genetic Risk
16%
Exome Sequencing
16%
Skeletal Muscle
12%
Single Nucleotide Polymorphism
10%
Protein P53
10%
Cabazitaxel
9%
Pedigree
9%
Ipilimumab
9%
Biopsy Technique
9%
Disease Predisposition
9%
Krukenberg Tumor
9%
Carboplatin
9%
Adipose Tissue
9%
Macrophage
8%
Cancer Susceptibility
8%
Genome Wide Association Study
7%
Overall Survival
6%
Odds Ratio
6%
BRCA1
6%
Tumor Protein
6%
Cell Cycle
6%
